Diaxxo AG

Point-of-care PCR diagnostics in every doctors studio

Diaxxo is a startup originated at ETH Zürich, where in the past 4 years we have developed and prototyped an innovative Point-of-Care Polymerase Chain Reaction (PCR) device. Our vision is to bring the power of molecular diagnostics to every doctors office, thanks also to our new pre-loaded PCR test kits that allow for simpler and faster sample preparation steps. During 2020 our devices have been used by more than 250 users for the rapid detection of Covid-19 in a field study that we run at ETH Zürich, and our systems are currently being tested also at the Swiss Tropical and Public Health Institute (Swiss TPH) and at the Tierspital Zürich. Several medical doctors have already expressed interest in our technology and we are now working towards the IVD certification.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

03.06.2024

Two weeks in Silicon Valley (startupticker.ch)

31.05.2022

Top 10 W. A. de Vigier finalists nominated (startupticker.ch)

No milestones

No Jobs

No videos and documents

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (50'000) 2020

Website